< Back to previous page
Project
Evaluation of commercialization roadmaps for a new target in MS (R-12677)
For a new therapeutic target for multiple sclerosis, the market potential and most optimal development route for successful commercialisation will be analysed. This will support downstream strategic decisions for the valorisation roadmap.
Date:1 Mar 2022 → 28 Feb 2023
Keywords:multiple sclerosis
Disciplines:Neurological and neuromuscular diseases, Neurosciences not elsewhere classified